Zepbound (tirzepatide) is the FDA-approved weight loss formulation delivering the most dramatic results in weight loss medication history—with users losing 20-25% of their body weight on average. As the weight-loss specific version of Mounjaro, Zepbound's dual GLP-1/GIP action produces results that exceed even Wegovy, but this power requires careful management to avoid "Zepbound face." Our AI visualizer shows you both paths: rapid transformation with facial volume loss versus a healthy, sustainable approach that preserves your youthful appearance while still achieving life-changing weight loss results.
What rapid weight loss looks like: gaunt cheeks, hollow temples, aged appearance.
What healthy transformation looks like: defined jawline, volume retention, radiant appearance.
Upload a photo to generate your personalized preview.
Full body shots or face close-ups supported
100% Private: We never store your original photo. Generated images are automatically permanently deleted after 1 hour.
Three simple steps to your new look.
Use a clear, full-body photo with good lighting for the best results.
Select "Lose Weight", "Muscle Gain", or "Shred" to guide our engine.
Our system processes your image and delivers a high-fidelity preview in seconds.
The same weight loss can look completely different depending on how you lose it. See all three stages of your transformation journey.
Your starting point before any weight loss
Your starting point before any weight loss
Rapid weight loss without proper nutrition - gaunt, hollow appearance
Healthy transformation with muscle retention - defined, glowing
Zepbound is the brand name for tirzepatide when prescribed specifically for chronic weight management (Mounjaro is the same medication for type 2 diabetes). It's a first-in-class dual GIP/GLP-1 receptor agonist, making it more potent than semaglutide-based medications like Wegovy. FDA-approved in November 2023, Zepbound represents the most effective prescription weight loss medication available, with clinical trials showing 20-25% body weight reduction over 72 weeks. This superior effectiveness also means users need to be even more strategic about protein intake and resistance training to preserve muscle mass and facial volume.
Zepbound is specifically formulated for weight loss, unlike Mounjaro which treats diabetes. This means you're likely starting it solely for weight management—making the "how" of your weight loss journey even more critical. The dual GIP/GLP-1 mechanism suppresses appetite so effectively that many Zepbound users report difficulty eating adequate calories, let alone hitting protein targets. In SURMOUNT-1 trials, participants lost an average of 48 pounds (22% body weight) at the highest dose. Without proper muscle preservation strategies, a significant portion of that loss comes from lean mass. The face—already having minimal muscle—shows this depletion dramatically. Our visualizer demonstrates the stark difference between two people who both lost 50 pounds on Zepbound: one who prioritized protein and strength training (vibrant, defined) versus one who relied solely on the medication (gaunt, aged). Same drug, same scale victory, completely different mirror outcome. The visualizer helps you commit to the right approach from day one.
Three simple steps to see your transformation paths
Use any clear photo of yourself. Full body works best, but face photos work too. The AI analyzes your facial structure and fat distribution.
Choose "Zepbound Transformation (Both Paths)" to see side-by-side comparisons of rapid loss versus healthy transformation. The AI generates both versions.
See both versions side-by-side. Use them to inform your nutrition strategy, training plan, and weight loss pacing decisions. Knowledge is power.
Explore our full suite of weight loss medication visualizers
See both transformation paths before you start
See realistic Ozempic transformation results
Preview your Wegovy weight loss journey
Visualize Mounjaro transformation results
See semaglutide facial transformation effects
Preview tirzepatide weight loss results
Both contain tirzepatide, but Zepbound is specifically FDA-approved for chronic weight management in adults with obesity or overweight conditions, while Mounjaro is approved for type 2 diabetes with weight loss as a side effect. The dosing and formulation are similar, but Zepbound is prescribed purely for weight loss, making proper nutrition and training even more essential since you don't have diabetes management as an additional focus.
Zepbound (tirzepatide) consistently produces more weight loss than Wegovy (semaglutide) in head-to-head trials—approximately 20-25% body weight loss versus 15-20% with Wegovy. However, the greater weight loss also means more opportunity for facial volume depletion if muscle isn't preserved. Both medications work best when combined with high protein intake and resistance training.
Absolutely. The key is maintaining muscle mass while losing fat. Aim for 0.8-1g protein per pound of body weight daily, resistance train 3-4 times per week, and pace your weight loss at 1-2 lbs per week maximum. Many users find that Zepbound's appetite suppression makes eating enough protein challenging, so prioritize protein at every meal before carbs or fats. Our visualizer shows exactly what the difference looks like.
